Information Technology
Clinical Trial Site Feasibility: from 6 Months to Minutes with Research Grid's New Automation Tool
Feasibility remains one of the most common bottlenecks in clinical research, with site selection and activation typically taking up to 6 months due to manual oversight, outdated site data, and inconsistent response rates:
said Dr. Amber Hill , founder and CEO of Research Grid.
Research Grid's new solution tackles these challenges head-on, matching protocol needs with real-world patient and infrastructure access, automating the process from outreach to activation.
The Site Feasibility Solution is available now, either as a self-service tool or a fully managed service, providing flexibility for feasibility on a single study or across an entire global portfolio.
This launch continues Research Grid's pioneering work to replace outdated manual processes with intelligent automation—making clinical trials faster, smarter, and more inclusive globally.
Research Grid is the automation engine for admin-free clinical trials. Far too many trials fail because of delays, errors, or weak patient engagement caused by legacy software and manual processes. Our mission is to enable faster, more successful clinical trials by engineering smart software that safely automates back-office admin across the full life cycle. Informed by deep expertise and first-hand experience, we have built comprehensive solutions for patient and community engagement (Inclusive) and clinical trial management (TrialEngine) that support a variety of trial types and therapeutic areas. Founded in 2020 by Dr Amber Hill , Research Grid is headquartered in London and has raised a total of $8 million in venture funding to date.
View original content:https://www.prnewswire.co.uk/news-releases/clinical-trial-site-feasibility-from-6-months-to-minutes-with-research-grids-new-automation-tool-302523485.html